Latest Production Development News

Acrux Limited has secured a decade-long licensing agreement with Servacure to commercialise its FDA-approved Dapsone 5% Gel in Saudi Arabia, marking a strategic step in its global expansion.

One Click Group Limited reported a 28% revenue increase to $1.3 million in H1 2025, launched a new $500 cash advance product, and surpassed 200,000 registered users, setting the stage for further growth.

Harvest Technology Group reports a 135% revenue increase in Q4 FY25, new leadership appointments, and a strategic listing on the Frankfurt Stock Exchange to broaden its investor base.

Simble Solutions Limited reported a $527k equity raise and secured significant software contracts in Australia and the UK during Q2 FY25, while advancing its AI integration strategy amid a soft quarter.

Enlitic, Inc. has confirmed its commitment to achieving operational cashflow break-even by the end of 2025, alongside maintaining its revenue guidance of US$9-11 million for the calendar year.

archTIS reports robust quarterly growth with a 17% rise in annual recurring revenue and key defence contracts secured across the US, UK, Japan, and Australia. A recent $7.5 million capital raise positions the company for further international expansion.

4DS Memory Limited reports mixed progress in its June 2025 quarter, with ongoing root cause analysis into unexpected wafer test results and a stable cash position of $10.2 million.

Enlitic reports a 48% revenue surge in Q2 FY25, secures a major $50 million partnership with GE HealthCare, and completes a $10 million equity raise, positioning itself for operational break-even by year-end.

Orbital Corporation reports a $0.5 million operating cash outflow for Q2 2025, while progressing development of a larger UAV engine now entering customer flight trials.

Jatcorp Limited reported a robust 76% revenue increase in Q4 FY25, driven by strong Moroka® sales and expanded manufacturing capabilities, setting ambitious growth targets for FY26.

Uscom Limited reported a significant revenue decline in Q4 2025 amid global market instability but is focusing on cost management and strategic partnerships to position for recovery.

ReNerve Limited reported a robust 53% increase in annual revenue, driven by strategic partnerships and new regulatory approvals that broaden its global footprint in nerve repair.